Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue and grant income:        
Government contract revenue $ 105 $ 435
Operating expenses:        
Research and development 1,978 954 5,491 3,436
General and administrative 1,616 1,135 3,973 3,102
Total operating expenses 3,594 2,089 9,464 6,538
Loss from operations (3,489) (2,089) (9,029) (6,538)
Other income (expense):        
Interest income, net 15 22 47 87
Foreign exchange gain (loss) 30 18 75 46
Total other income, net 45 40 122 133
Net loss $ (3,444) $ (2,049) $ (8,907) $ (6,405)
Net loss per common share, basic $ (0.20) $ (0.19) $ (0.59) $ (0.61)
Net loss per common share, diluted $ (0.20) $ (0.19) $ (0.59) $ (0.61)
Weighted average number of common shares outstanding, basic 17,419 10,991 15,011 10,449
Weighted average number of common shares outstanding, diluted 17,419 10,991 15,011 10,449